Apoptogenth Ltd

United Kingdom
unknown
unknown
Stage

About

Apoptogenth Ltd is a University of Leeds spin-out developing a haematopoietic stem cell gene therapy that uses tumour-infiltrating myeloid cells as a 'Trojan Horse' to deliver apoptosis-inducing genes directly to brain metastases. The approach targets metastatic brain tumours that are difficult to treat with conventional therapies.

Explore Apoptogenth Ltd's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.